Stock Fundamentals

Company Information

Company Name
BioAge Labs, Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US09077V1008
CIK: 0001709941
CUSIP: 09077V100
Currency: USD
Full Time Employees: 60
Phone: 510 806 1445
Fiscal Year End: December
IPO Date: Sep 26, 2024
Description:

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Address:

5885 Hollis Street, EmeryVille, CA, United States, 94608

Directors & Officers

Name Title Year Born
Dr. Kristen Fortney Ph.D. Co-Founder, CEO, President, Treasurer, Secretary & Director 1984
Dr. Eric Morgen M.D. Co-Founder, COO & Director 1983
Dr. Paul D. Rubin M.D. Chief Medical Officer & Executive VP of Research 1954
Dr. Dov A. Goldstein M.B.A., M.D. Chief Financial Officer 1967
Mr. Shane Barton CPA Senior Vice President of Finance & Accounting 1971
Mr. Rusty Montgomery Ph.D. Senior Vice President of Research NA
Ms. Julie Gammelgard Senior Vice President of People NA
Dr. Peng Leong M.B.A., Ph.D. Chief Business Officer & Therapeutic Area Head of Brain Aging NA
Mr. BJ Sullivan Ph.D. Chief Strategy Officer NA
Ms. Ann C. Neale RN BSN Chief Development Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 02, 2026 Paul D Rubin N/A Sale 7.43K $18.75 $139.37K
Jan 13, 2026 Dov A Md Goldstein N/A Sale 27.00K $19.70 $531.90K
Jan 13, 2026 Kristen Fortney N/A Sale 233.11K $18.12 $4.22M
Dec 09, 2025 Paul D Rubin N/A Sale 18.00K $12.00 $216.00K
Dec 04, 2025 Paul D Rubin N/A Sale 68.90K $10.19 $702.06K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Cormorant Asset Management, LLC 2.89M Mar 31, 2026 6.50% $2.54 41.65%
Sofinnova Ventures 2.29M Mar 31, 2026 5.16% $1.52 0.00%
BlackRock Inc 2.27M Mar 31, 2026 5.10% $0.00 48.46%
HHG PLC 2.09M Mar 31, 2026 4.71% $0.02 411.79%
Octagon Capital Advisors LP 1.75M Mar 31, 2026 3.93% $3.38 9.39%
RA Capital Management, LLC 1.65M Mar 31, 2026 3.71% $0.31 0.00%
Vanguard Group Inc 1.41M Dec 31, 2025 3.18% $0.00 -14.32%
Vanguard Capital Management, LLC 1.35M Mar 31, 2026 3.05% $0.00 0.00%
Balyasny Asset Management LLC 1.33M Mar 31, 2026 2.99% $0.03 0.00%
BRAIDWELL LP 1.20M Mar 31, 2026 2.70% $0.70 0.00%
Polar Capital Holdings PLC 1.13M Mar 31, 2026 2.55% $0.07 0.00%
State Street Corp 850.89K Mar 31, 2026 1.91% $0.00 101.23%
Sands Capital Ventures, LLC 786.35K Mar 31, 2026 1.77% $3.27 0.00%
Geode Capital Management, LLC 749.27K Mar 31, 2026 1.69% $0.00 26.70%
Orbimed Advisors, LLC 711.81K Mar 31, 2026 1.60% $0.25 -10.00%
D. E. Shaw & Co LP 699.19K Mar 31, 2026 1.57% $0.01 105.70%
StemPoint Capital LP 677.31K Mar 31, 2026 1.52% $1.14 0.00%
Pivotal bioVenture Partners Investment Advisor LLC 653.37K Mar 31, 2026 1.47% $4.08 0.00%
Cosmic Management, LLC 501.83K Mar 31, 2026 1.13% $3.84 0.00%
Adage Capital Partners Gp LLC 500.00K Mar 31, 2026 1.12% $0.01 -52.38%

Shares Statistics

Shares Outstanding: 44.45M
Shares Float: 34.95M
% Insiders: 243.80%
% Institutions: 8,548.50%
Short % Float: 9.51%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Polar Capital Biotech S Inc 1.07M 2.41% ▲ 0.00% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 985.49K 2.22% ▲ 0.00% Apr 30, 2026
3 iShares Russell 2000 ETF 725.32K 1.63% ▲ 0.93% May 29, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 338.24K 0.76% ▲ 0.54% Apr 30, 2026
5 Fidelity Small Cap Index 296.60K 0.67% ▲ 27.53% Mar 31, 2026
6 iShares Russell 2000 Value ETF 264.82K 0.60% ▲ 0.00% May 29, 2026
7 State Street® SPDR® S&P® PhrmctlsETF 228.47K 0.51% ▲ 0.00% May 31, 2026
8 iShares Biotechnology ETF 211.10K 0.47% ▲ 1.96% May 29, 2026
9 State St Russell Sm/Mid Cp® Indx SL Cl I 176.80K 0.40% ▲ 0.00% May 31, 2026
10 Fidelity Enhanced Small Cap Core ETF 166.64K 0.37% ▲ 0.25% May 29, 2026

Valuation Metrics

Enterprise Value: $702.82M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.08B
EBITDA: $-101.47M
Book Value: $8.54
Earnings/Share: $-2.35
Profit Margin: 0.00%
Operating Margin: -915.40%
ROA (TTM): -17.15%
ROE (TTM): -25.98%
Revenue (TTM): $10.32M
Revenue/Share (TTM): $0.27
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 91.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 14.24x 0.01x 0.08x -133.11x -0.04x
2024-12-31 12.86x 0.03x 0.10x -33.04x -0.13x
2023-12-31 0.44x -0.31x 7.69x -6.21x -0.95x
2022-12-31 4.78x -0.02x 4.96x -165.85x -0.06x
2017-12-31 1.35x 0.23x 0.69x N/A -0.06x
2016-12-31 0.69x 0.48x 0.70x N/A -1.75x
2015-12-31 0.37x 0.22x 0.68x N/A -0.31x
2014-12-31 2.49x 0.05x 0.62x N/A -0.07x
2013-12-31 5.33x 0.10x 0.43x -5.54x -0.17x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BIOA.US!